Analgesic Effect of Ultrasound-Guided Transversus Abdominis Plane Block in Femoral Endovascular Cardiac Interventions A Prospective Randomized Study

What this Trial Is About

Researchers are studying the use of an ultrasound-guided transversus abdominis plane block (TAPB) to provide pain relief during femoral endovascular cardiac interventions such as coronary angiography, cardiac catheterization, and percutaneous coronary intervention. These procedures often involve accessing the femoral artery, which has complex sensory nerves thought to be mainly supplied by the ilioinguinal and iliohypogastric nerves. The study aims to evaluate how well TAPB provides analgesia and to assess both patient and physician satisfaction during the procedure. Participants will be randomly assigned to one of two groups. One group will receive only the routine local anesthesia applied to the surgical field, while the other group will receive the routine local anesthesia plus the TAPB under ultrasound guidance using 10 ml of 2% lidocaine. The TAPB targets the nerve branches that supply sensation to the intervention area. The study is double-blinded and prospective, assessing the analgesic effect and satisfaction over a period of 4 months. During the study, patients will undergo their scheduled cardiac intervention with the assigned anesthesia approach. Researchers will measure the analgesic effectiveness of TAPB and gather satisfaction ratings from patients and physicians using a 5-point Likert scale, where higher scores indicate better satisfaction. The study includes continuous monitoring and data collection during the procedure and follow-up over 4 months to evaluate outcomes related to pain relief and procedure experience.

Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions